# Novugen Oncology Sdn. Bhd. – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/novugen-oncology-sdn-bhd/563695a7-e145-4f34-8dec-a6d855026b89
Source feed: FDA_Inspections

> FDA inspection 1210629 of Novugen Oncology Sdn. Bhd., July 21, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210629
- Company Name: Novugen Oncology Sdn. Bhd.
- Inspection Date: 2023-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- [FDA Inspection 1332766 - 2026-08-07](https://www.keypedia.com/records/fda_inspections/novugen-oncology-sdn-bhd/2626f307-7808-4f94-93e6-442f246d0393)

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/novugen-oncology-sdn-bhd/7e1b6b37-6dc6-4ab8-9389-160d85c8111f

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8